Bumrungrad Hospital Public Company BUGDF Stock
Bumrungrad Hospital Public Company Price Chart
Bumrungrad Hospital Public Company BUGDF Financial and Trading Overview
| Bumrungrad Hospital Public Company stock price | 5.4 USD |
| Previous Close | 4.75 USD |
| Open | 5.4 USD |
| Bid | 5.5 USD x 20000 |
| Ask | 7.15 USD x 10000 |
| Day's Range | 5.4 - 5.4 USD |
| 52 Week Range | 3.95 - 6.31 USD |
| Volume | 2K USD |
| Avg. Volume | 0 USD |
| Market Cap | 4.29B USD |
| Beta (5Y Monthly) | 0.241 |
| PE Ratio (TTM) | 20 |
| EPS (TTM) | 0.27 USD |
| Forward Dividend & Yield | 0.15 (3.25%) |
| Ex-Dividend Date | March 17, 2026 |
| 1y Target Est | N/A |
BUGDF Valuation Measures
| Enterprise Value | -10144667648 USD |
| Trailing P/E | 20 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 4 |
| Price/Sales (ttm) | 0.16841072 |
| Price/Book (mrq) | 4.285067 |
| Enterprise Value/Revenue | -0.398 |
| Enterprise Value/EBITDA | -1 |
Trading Information
Bumrungrad Hospital Public Company Stock Price History
| Beta (5Y Monthly) | 0.241 |
| 52-Week Change | -24.72% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 6.31 USD |
| 52 Week Low | 3.95 USD |
| 50-Day Moving Average | 4.75 USD |
| 200-Day Moving Average | 4.6 USD |
BUGDF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 794.97M |
| Float | 713.11M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 9.44% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 5 |
| Trailing Annual Dividend Yield | 105.26% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.5774 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 29.69% |
| Operating Margin (ttm) | 34.69% |
| Gross Margin | 52.40% |
| EBITDA Margin | 39.78% |
Management Effectiveness
| Return on Assets (ttm) | 15.70% |
| Return on Equity (ttm) | 24.37% |
Income Statement
| Revenue (ttm) | 25.49B USD |
| Revenue Per Share (ttm) | 32.07 USD |
| Quarterly Revenue Growth (yoy) | 0.70% |
| Gross Profit (ttm) | 13.36B USD |
| EBITDA | 10.14B USD |
| Net Income Avi to Common (ttm) | 7.57B USD |
| Diluted EPS (ttm) | 0.27 |
| Quarterly Earnings Growth (yoy) | 3.20% |
Balance Sheet
| Total Cash (mrq) | 14.34B USD |
| Total Cash Per Share (mrq) | 18.04 USD |
| Total Debt (mrq) | 103.64M USD |
| Total Debt/Equity (mrq) | 0.31 USD |
| Current Ratio (mrq) | 4.484 |
| Book Value Per Share (mrq) | 1.2601904 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 7.7B USD |
| Levered Free Cash Flow (ttm) | 3.18B USD |
Profile of Bumrungrad Hospital Public Company
| Country | United States |
| State | N/A |
| City | Bangkok |
| Address | 33 Sukhumvit Soi 3 (Nana Nua) |
| ZIP | 10110 |
| Phone | 66 2 066 8888 |
| Website | https://www.bumrungrad.com |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Bumrungrad Hospital Public Company Limited owns and operates hospitals and healthcare centers in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, pediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology and nuclear medicine, digestive disease, ear, nose, throat, emergency, endocrinology, esperance, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopaedics, perinatal, plastic surgery, pulmonary, refractive surgery, memory, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, IVF, hearing and balance, medical, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, and vaccine clinics and centers. In addition, it operates spine institute, heart institute, and intensive care unit; and offers nutrition services, pharmacy services, preventive genomics and integrative medicine services. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.
Q&A For Bumrungrad Hospital Public Company Stock
What is a current BUGDF stock price?
Bumrungrad Hospital Public Company BUGDF stock price today per share is 5.4 USD.
How to purchase Bumrungrad Hospital Public Company stock?
You can buy BUGDF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bumrungrad Hospital Public Company?
The stock symbol or ticker of Bumrungrad Hospital Public Company is BUGDF.
Which industry does the Bumrungrad Hospital Public Company company belong to?
The Bumrungrad Hospital Public Company industry is Medical Care Facilities.
How many shares does Bumrungrad Hospital Public Company have in circulation?
The max supply of Bumrungrad Hospital Public Company shares is 794.97M.
What is Bumrungrad Hospital Public Company Price to Earnings Ratio (PE Ratio)?
Bumrungrad Hospital Public Company PE Ratio is 20.00000000 now.
What was Bumrungrad Hospital Public Company earnings per share over the trailing 12 months (TTM)?
Bumrungrad Hospital Public Company EPS is 0.27 USD over the trailing 12 months.
Which sector does the Bumrungrad Hospital Public Company company belong to?
The Bumrungrad Hospital Public Company sector is Healthcare.